⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30061271 | 1.00 | — | — | |
| SCHEMBL29465180 | 1.00 | — | — | |
| Bromide SCHEMBL3714719 | 0.98 | — | — | |
| Bromide SCHEMBL21807137 | 0.98 | — | — | |
| SCHEMBL19348393 | 0.79 | — | — | |
| SCHEMBL30891801 | 0.76 | — | — | |
| SCHEMBL30657174 | 0.76 | — | — | |
| SCHEMBL375904 | 0.70 | — | — | |
| SCHEMBL17310959 | 0.70 | — | — | |
| SCHEMBL28165752 | 0.67 | SLC18A3 (0.35) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 227 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12384789-B2 | Compounds for treating Huntington's disease | PTC THERAPEUTICS, INC. (US) | 2025-08-12 | — | — | US | claimed |
| CN-119528903-A | Compounds for the treatment of spinal muscular atrophy | PTC医疗公司 | 2025-02-28 | — | — | CN | claimed |
| US-20240425517-A1 | NOVEL COMPOUND FOR DEGRADATION OF TARGET PROTEIN OR POLYPEPTIDE BY POLYUBIQUITINATION | PRAZER THERAPEUTICS INC. (KR) | 2024-12-26 | — | — | US | claimed |
| US-12157094-B2 | Gas separation method with multilayer membrane | KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) | 2024-12-03 | — | — | US | claimed |
| CN-108299314-B | Compounds for the treatment of spinal muscular atrophy | PTC医疗公司 | 2024-11-26 | — | — | CN | claimed |
| US-12138596-B2 | Method for separating carbon dioxide and methane | KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) | 2024-11-12 | — | — | US | claimed |
| US-12102967-B2 | Method for separating a gas stream to isolate carbon dioxide | KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) | 2024-10-01 | — | — | US | claimed |
| US-12102966-B2 | CO2 gas enrichment method | KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) | 2024-10-01 | — | — | US | claimed |
| CN-111065626-B | Compounds for the treatment of huntington's disease | PTC医疗公司 | 2024-09-27 | — | — | CN | claimed |
| US-20240278190-A1 | GAS SEPARATION METHOD WITH MULTILAYER MEMBRANE | KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) | 2024-08-22 | — | — | US | claimed |
| WO-2022234965-A1 | HETEROARYL DERIVATIVE, METHOD FOR PREPARING SAME, AND PHARMACEUTICAL COMPOSITION COMPRISING SAME AS ACTIVE INGREDIENT | 주식회사 보로노이 | 2022-11-10 | — | — | WO | claimed |
| EP-4081509-A1 | NOVEL COMPOUNDS SUITABLE FOR THE TREATMENT OF DYSLIPIDEMIA | Zydus Lifesciences Limited (IN) | 2022-11-02 | — | — | EP | claimed |
| CN-114901640-A | Novel compounds useful for the treatment of dyslipidemia | 兹杜斯生命科学有限公司 | 2022-08-12 | — | — | CN | claimed |
| US-20220251098-A1 | COMPOUNDS FOR TREATING HUNTINGTON'S DISEASE | PTC THERAPEUTICS, INC. | 2022-08-11 | — | — | US | claimed |
| US-11382918-B2 | Methods for treating Huntington's Disease | PTC THERAPEUTICS, INC. (US) | 2022-07-12 | — | — | US | claimed |
| WO-2021130723-A1 | NOVEL COMPOUNDS SUITABLE FOR THE TREATMENT OF DYSLIPIDEMIA | CADILA HEALTHCARE LIMITED (IN) | 2021-07-01 | — | — | WO | claimed |
| US-20200206695-A1 | LAYERED CDC-POLYAMIDE MEMBRANE AND ITS MAKE AND USE | KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) | 2020-07-02 | — | — | US | claimed |
| CN-108473485-A | QUINOLIN-2-ONE DERIVATIVES | 默克专利股份公司 | 2018-08-31 | — | — | CN | claimed |
| CN-107567453-A | (base of indazole 4) hexahydropyrrolo and pyrrolones and application method | 艾伯维公司 | 2018-01-09 | — | — | CN | claimed |
| CN-104684915-B | Novel bicyclic derivative | 霍夫曼-拉罗奇有限公司 | 2017-10-31 | — | — | CN | claimed |